AbbVie (MEX:ABBV) Dividend Payout Ratio: 0.65 (As of Mar. 2026) — 38% Above Median


MEX:ABBV AbbVie Inc MEX:ABBV
72 GF Score
Price MXN4,343.00
GF Value MXN3,624.05
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is AbbVie Dividend Payout Ratio?

AbbVie MEX:ABBV +2.31% 72 Dividend Payout Ratio is 0.65 as of Mar. 2026, which is 38% above its 10-year median of 0.47. GuruFocus rates MEX:ABBV with a GF Score™ of 72/100 and a GF Value™ of MXN3,624.05 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 444 Drug Manufacturers companies, AbbVie ranks worse than 78.15% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. AbbVie's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.65.

The historical rank and industry rank for AbbVie's Dividend Payout Ratio or its related term are showing as below:

MEX:ABBV' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.41   Med: 0.47   Max: 0.66
Current: 0.65

During the past 13 years, the highest Dividend Payout Ratio of AbbVie was 0.66. The lowest was 0.41. And the median was 0.47.

MEX:ABBV's Dividend Payout Ratio is ranked worse than
78.15% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs MEX:ABBV: 0.65

As of today (2026-06-29), the Dividend Yield % of AbbVie is 2.78%.

During the past 13 years, the highest Trailing Annual Dividend Yield of AbbVie was 6.30%. The lowest was 2.08%. And the median was 3.64%.

AbbVie's Dividends per Share for the months ended in Mar. 2026 was MXN31.20.

During the past 12 months, AbbVie's average Dividends Per Share Growth Rate was 5.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 5.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 13.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of AbbVie was 23.40% per year. The lowest was 5.20% per year. And the median was 12.80% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

AbbVie (MEX:ABBV) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

AbbVie Dividend Payout Ratio Related Terms

AbbVie Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for AbbVie's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie Dividend Payout Ratio Chart

AbbVie Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.41 0.53 0.61 0.66

AbbVie Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.55 0.88 0.61 0.65

MEX:ABBV vs MRK, JNJ, AMGN: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, AbbVie's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbbVie Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Dividend Payout Ratio falls into.


MEX:ABBV
72GF Score
AbbVie Inc MEX:ABBV
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AbbVie Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

AbbVie's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=118.117/ 180.057
=0.66

AbbVie's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=31.197/ 47.787
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.65 mean?
AbbVie (MEX:ABBV) has a Dividend Payout Ratio of 0.65 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on AbbVie and its competitors. This is 38% above median its historical median of 0.47. Over the past decade, AbbVie's Dividend Payout Ratio has ranged from 0.41 to 0.66. According to the industry distribution chart, AbbVie ranks #347 out of 444 companies in the Drug Manufacturers industry, placing it in the top 78.2%.
Is AbbVie's Dividend Payout Ratio too high?
AbbVie's current Dividend Payout Ratio of 0.65 is 38% above median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 0.66. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. AbbVie's value of 0.65 is 73.3% above this industry median. Based on the distribution chart, AbbVie ranks #347 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, AbbVie has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbbVie's Dividend Payout Ratio compare to MRK and JNJ?
According to the Drug Manufacturers industry distribution chart, AbbVie ranks #347 out of 444 companies for Dividend Payout Ratio. This places AbbVie in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. AbbVie's value of 0.65 is 73.3% above this benchmark. Historically, AbbVie's own Dividend Payout Ratio has ranged from 0.41 to 0.66 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 0.38, AbbVie has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AbbVie's current Dividend Payout Ratio of 0.65 is 73.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on AbbVie and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AbbVie's current Dividend Payout Ratio is 0.65, which is 38% above median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
Based on GuruFocus' analysis, AbbVie (MEX:ABBV) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,624.05, compared to a current price of MXN4,343.00 — trading 19.8% above its estimated fair value. The current Dividend Payout Ratio is 0.65, which is 38% above median its 10-year median of 0.47 and 73.3% above the Drug Manufacturers industry median of 0.38. AbbVie's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For AbbVie (MEX:ABBV), the current Dividend Payout Ratio is 0.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AbbVie (MEX:ABBV) Overvalued in 2026?

Based on GuruFocus' analysis, AbbVie stock appears to be overvalued. The current stock price of MXN4,343.00 is trading 19.8% above its estimated GF Value™ of MXN3,624.05. GuruFocus considers AbbVie to be Modestly Overvalued.

Key valuation signals for MEX:ABBV:

  • Dividend Payout Ratio: 0.65 (38% above median its 10-year median of 0.47)
  • GF Value™: MXN3,624.05 vs. price of MXN4,343.00 (19.8% above fair value)
  • GF Score™: 72/100 with 4 warning signs
  • Industry Position: 73.3% above the Drug Manufacturers median (#347 of 444)

No single metric tells the full story. See the MEX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AbbVie Business Description

Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
72GF Score

Get the complete analysis for MEX:ABBV

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,343.00
Price
MXN3,624.05
GF Value